COR
CENCORA, INC.NYSEResearch view
Consumer Defensive · Wholesale-Drugs, Proprietaries & Druggists' Sundries · Large-cap · SEC EDGAR FY 2025-09-30
Price history
Chart: TradingView’s own feed · page prices: 1D EOD🔒 Click to interact · scroll moves the page
Snapshot
SEC EDGAR · FY 2025-09-30SectorConsumer Defensive
Market Cap$58.9B
Enterprise Value$62.3B
Income$1.6B
Sales$321.3B
Book/sh$9.16
Cash/sh$23.03
Dividend TTM$2.20
Payout28%
Employees—
IPO—
Quick Ratio0.55
Current Ratio0.90
Debt/Eq4.45
EPS (ttm)$7.96
EPS this Y5.7%
EPS past 3/5Y-0.3%
Sales past 3/5Y10.4%
EPS Y/Y TTM5.7%
Sales Y/Y TTM9.3%
Shs Outstand190.83M
ROA2.0%
ROE89.0%
ROIC35.6%
Gross Margin3.6%
Oper. Margin0.8%
Profit Margin0.5%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$214.0B
2021
$238.6B
2022
$262.2B
2023
$294.0B
2024
$321.3B
2025
Financials — annual
SEC EDGAR · last 5 FY · tap a row to explain it| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $214.0B | $238.6B | $262.2B | $294.0B | $321.3B |
| Gross Profit | $6.9B | $8.3B | $9.0B | $9.9B | $11.5B |
| Operating Income | $2.4B | $2.4B | $2.3B | $2.2B | $2.6B |
| Net Income | $1.5B | $1.7B | $1.7B | $1.5B | $1.6B |
| Diluted EPS | $7.39 | $8.04 | $8.53 | $7.53 | $7.96 |
| Operating Cash Flow | $2.7B | $2.7B | $3.9B | $3.5B | $3.9B |
| Free Cash Flow | $2.2B | $2.2B | $3.5B | $3.0B | $3.2B |
Deep dive
Computed from the SEC EDGAR multi-year statementsOperating leverage — margins
GrossOperatingNet
FY25 cash-flow waterfall
Capital-light: capex is $668.0M against $3.9B operating cash
Follow the news. Track the move.
COR story timeline
Company updates and connected market context, with the dated price move attached.
1
Stories
1
Direct
COMMUNITY · $COR0 theses
POST YOUR TAKE →Related Stocks
Click to exploreSame Industry · Wholesale-Drugs, Proprietaries & Druggists' Sundries
Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.